Probity Advisors, Inc.

Position in GSK — GSK plc

CIK 1676603 DALLAS, TX

Position in GSK

as of Jun 30, 2026 · filed Jul 31, 2026 Compact

Position Value

$1,277,842

-$71,663 QoQ

Shares Held

24,377

-0.3% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.72%

of 13F equity value

Holder Rank

#316

of 1,033 holders

Holding Since

Jun 2023

13 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Probity Advisors, Inc. holds $17,628,696 across 10 Drug Manufacturers - General names. GSK ranks #6 (7.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	2,714	$3,255,253
2	ABBV	AbbVie Inc.	12,209	$3,072,272
3	MRK	Merck & Co., Inc.	19,934	$2,561,519
4	JNJ	Johnson & Johnson	9,274	$2,355,317
5	GILD	Gilead Sciences, Inc.	12,128	$1,532,251
6	GSK	GSK plc This page	24,377	$1,277,842
7	PFE	Pfizer Inc	50,988	$1,227,791
8	BMY	Bristol Myers Squibb Co	20,006	$1,152,745

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,277,842	24,377	-0.3%	Shares	Sole	2026-07-31
2026-03-31	$1,349,505	24,452	-1.3%	Shares	Sole	2026-04-28
2025-12-31	$1,214,966	24,775	-2.7%	Shares	Sole	2026-01-27
2025-09-30	$1,098,465	25,451	+7.5%	Shares	Sole	2025-10-30
2025-06-30	$909,504	23,685	+23.4%	Shares	Sole	2025-07-30
2025-03-31	$743,846	19,201	+27.0%	Shares	Sole	2025-05-09
2024-12-31	$511,358	15,120	+58.8%	Shares	Sole	2025-03-05
2024-09-30	$389,218	9,521	-1.2%	Shares	Sole	2024-10-16
2024-06-30	$371,140	9,640	+5.0%	Shares	Sole	2024-08-14
2024-03-31	$393,546	9,180	-7.6%	Shares	Sole	2024-05-03
2023-12-31	$368,339	9,939	+26.5%	Shares	Sole	2024-02-12
2023-09-30	$284,743	7,855	+38.1%	Shares	Sole	2023-11-14
2023-06-30	$202,684	5,687	—	Shares	Sole	2023-08-10
No filing history on record for this holder in this stock.